News and Press Releases

Fortrea Completes Divestiture of Endpoint Clinical and Patient Access Businesses to Arsenal Capital Partners

4 June 2024 -- North Carolina, US -- Fortrea a leading global contract research organisation (CRO), today announced it has completed the divestiture of assets relating to its Enabling Services segment,...

Category: Biotechnology, Clinical Trials, Pharmaceutical
Posted: June 4, 2024

8 Moore Drive Durham, NC 27703